1-27100384-T-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_003047.5(SLC9A1):āc.2371A>Gā(p.Ile791Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,593,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_003047.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9A1 | NM_003047.5 | c.2371A>G | p.Ile791Val | missense_variant | 12/12 | ENST00000263980.8 | NP_003038.2 | |
SLC9A1 | XM_011542021.4 | c.2041A>G | p.Ile681Val | missense_variant | 13/13 | XP_011540323.1 | ||
SLC9A1 | XM_047428769.1 | c.2041A>G | p.Ile681Val | missense_variant | 16/16 | XP_047284725.1 | ||
SLC9A1 | NR_046474.2 | n.2701A>G | non_coding_transcript_exon_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9A1 | ENST00000263980.8 | c.2371A>G | p.Ile791Val | missense_variant | 12/12 | 1 | NM_003047.5 | ENSP00000263980.3 | ||
SLC9A1 | ENST00000374089.5 | n.1596A>G | non_coding_transcript_exon_variant | 7/7 | 2 | |||||
SLC9A1 | ENST00000447808.1 | n.848A>G | non_coding_transcript_exon_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152150Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000603 AC: 14AN: 232196Hom.: 0 AF XY: 0.0000403 AC XY: 5AN XY: 124140
GnomAD4 exome AF: 0.000128 AC: 184AN: 1441516Hom.: 0 Cov.: 38 AF XY: 0.000129 AC XY: 92AN XY: 715080
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152150Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.2371A>G (p.I791V) alteration is located in exon 12 (coding exon 12) of the SLC9A1 gene. This alteration results from a A to G substitution at nucleotide position 2371, causing the isoleucine (I) at amino acid position 791 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 29, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with SLC9A1-related conditions. This variant is present in population databases (rs140754742, gnomAD 0.01%). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 791 of the SLC9A1 protein (p.Ile791Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at